Skip to main content

Table 4 Comparison between various quantitative phenotypes in groups of NAFLD patients with different SNP genotypes at rs2290602

From: Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD)

 

GG

GT+TT

p value

GG+GT

TT

p value

N

14

101

 

80

35

 

Age (years)

48.5 + 18.5

49.5 + 14.7

0.8303

48.4 + 14.4

51.7 + 16.4

0.2913

BMI (kg/m2)

27.3 + 7.2

27.2 + 4.8

0.9194

27.0 + 5.1

27.6 + 4.9

0.5581

FBS (mg/dl)

118.5 + 26.3

117.3 + 32.9

0.8929

116.8 + 32.0

118.7 + 32.8

0.7791

IRI (ul/ml)

13.6 + 6.2

13.7 + 8.9

0.9778

12.9 + 6.9

15.4 + 11.6

0.1865

HbA1c (%)

5.39 + 1.26

5.88 + 1.26

0.1890

5.83 + 1.28

5.80 + 1.23

0.9138

Total cholesterol (mg/dl)

219.1 + 35.7

213.1 + 39.3

0.6017

214.7 + 39.5

211.6 + 37.5

0.6978

HDL cholesterol (mg/dl)

50.6 + 10.0

53.3 + 22.0

0.6709

51.2 + 16.2

57.0 + 29.1

0.1800

Triglycerides (mg/dl)

144.9 + 53.7

172.1 + 116.4

0.4102

159.1 + 70.4

192.2 + 172.3

0.1469

AST (U/ml)

35.0 + 12.2

45.8 + 27.5

0.1660

40.4 + 21.3

54.5 + 34.1

0.0085

ALT (U/ml)

50.4 + 27.2

73.4 + 55.7

0.1462

62.7 + 37.7

89.9 + 76.9

0.0127

VFA (cm2)

129.3 + 32.9

135.8 + 50.0

0.7585

135.4 + 47.4

134.9 + 51.3

0.9703

SFA (cm2)

274.6 + 148.9

229.4 + 116.8

0.3821

235.4 + 123.8

230.4 + 114.2

0.8709

  1. Data are shown as means ± SD. VFA: visceral fat area, SFA: subcutaneous fat area, AST: aspartate aminotransferase, ALT: alanine aminotransferase, FBS: fasting blood sugar, IRI: Immunoreactive insulin,